Intake & Output
Why your protocol stalled, which side is actually failing, and what the research suggests doing before you change anything.
Not medical advice. Not a dosing recommendation. Not a sourcing guide. Every compound here is a research compound and every framework is an educational reference point drawn from published literature and documented research practice.
Are you a member?
This guide is part of the Project Theo guides library. If you have a guides library membership, a Protocol Builder subscription, or Full Access, enter the email on your subscription to open the full guide. If not, you can read it as a guest and see exactly what every section covers.
Not a member yet? The guides library opens every guide at one monthly price. Full Access adds the Protocol Builder, the Stack Visualizer and the research search engine on top of that. See membership options
The Two Reasons
Why compound selection without a diagnosis is expensive noise
Most researchers who hit a plateau think they need a stronger compound. They escalate the dose, or they switch to something that sounds more powerful. The scale does not move. Sometimes it goes the wrong way. The reason is almost never the compound. It is the diagnosis.
Once intake is actually measured and the foundation is stable, a stall almost always traces back to one of two things. Intake control failed, or output capacity failed. Intake is how much food goes in. Output is how much energy your body is willing and able to burn. They are completely different problems, they produce different symptoms, and they need completely different compounds. Using the wrong one does not just fail to help. It can make the problem worse.
Researchers who confuse the two make the same mistake in the same order. They watch the scale slow, decide the appetite compound stopped working, and escalate it. What they have actually done is add more suppression to a problem that is no longer about suppression. If intake was already controlled and confirmed, more appetite suppression is not the lever, and the body responds to the added pressure by conserving energy harder. Output falls further. The plateau holds.
The Foundation Gate
Four inputs that have to be stable before any compound gives you a clean read
Peptides amplify what is already there. They do not replace broken infrastructure. If any of the four below fails, that input is the first intervention, not a compound. Answer honestly. The gate is more useful when it fails.
Are you sleeping at least six hours most nights, and is the quality decent?
Short sleep raises cortisol, the stress hormone, and increases oxidative stress, which is the cellular wear that damages mitochondria. Mitochondria are the parts of the cell that turn food into usable energy. When they are under that load, every metabolic compound underperforms.
Fix sleep first. No compound has been shown to compensate for chronic short sleep, and running one on top of it wastes the compound and the read you would have got from it.
Can you get to normal energy without caffeine or other stimulants?
Daily stimulants raise cortisol and oxidative stress, so you are damaging mitochondria while trying to support them. Over time the body conserves energy harder, fatigue deepens, and the usual response is to escalate the stimulant. That cycle accelerates the problem it is treating.
Reduce the load before adding any metabolic compound. This one also shows up later as Pattern 3, where the honest answer is that no compound is the right tool yet.
Has your stress load been manageable, or has it been high for months?
Cortisol sets the ceiling on what any compound can accomplish. It works directly against fat mobilization, it increases hunger, it degrades sleep, and it contributes to oxidative stress at the mitochondrial membrane. It is a common and under checked contributor to plateaus, and it is almost never the thing people look at first.
If chronic stress is unmanaged, that is the limiting variable. Not the compound.
Are you doing resistance training three to four times a week?
Peptides amplify signals. Without a training signal telling the body to hold onto muscle, growth hormone compounds have nothing to protect. Without a demand to adapt to, metabolic compounds have almost nothing to amplify.
If training is absent, growth hormone and metabolic compounds produce a fraction of their documented effect. That is not the compound failing.
Which Side Is Limiting
A plain language self assessment. Tick what is actually true.
The self assessment that decides everything downstream. Ten plain language symptoms across two columns, and a read that tells you which side is actually limiting you right now. It also catches the most common error in the whole framework, which is calling something an output problem when intake was never actually measured.
The Three Energy Patterns
Why energy fails, and why the wrong tool makes it worse
Three energy patterns explain almost every plateau, and each one has a compound that helps and a compound that makes it worse. Two questions land you on yours, with the mechanism explained, the rational tool named, and the wrong choice named alongside it. Getting this backwards is what sends researchers rotating through compounds for months.
Intake Compounds
Semaglutide · Tirzepatide · Tesofensine · Cagrilintide · Retatrutide
Five intake compounds in full. Semaglutide, tirzepatide, tesofensine, cagrilintide and retatrutide, each with mechanism in plain English, the phase it belongs in, reported research ranges, what right and wrong looks like for your phase, the signs it is working, the signs something is off, and the stack conflicts that quietly cost you results.
Output Compounds
NAD+ · MOTs-c · SS-31 · AICAR · 5-Amino-1MQ
Five output compounds covering NAD+, MOTs-c, SS-31, AICAR and 5-Amino-1MQ, in the same depth. It opens with an honest account of how thin the human evidence is for this class, because writing them in the same confident voice as the GLP-1s would be dishonest. The sequencing rule alone is the thing most output protocols get wrong.
Recovery and Support
Tesamorelin · CJC-1295 · Ipamorelin · BPC-157 · TB-500
The support layer. Tesamorelin, CJC-1295, Ipamorelin, BPC-157 and TB-500, plus the conditions that have to be true before any of them do anything measurable. Includes the two redundant stacks researchers run constantly without realising both compounds are underperforming.
Phase Map
What to add, what to avoid, and when to reassess
The whole framework on one screen. Three phases, the limiting variable in each, the signals that confirm it, what belongs there and what to avoid. Closes with the three questions worth asking before any protocol change, which are about whether the thing you are about to change is the thing that is actually wrong.
All 15 Compounds
Class, mechanism, phase and stack rule at a glance
All fifteen compounds in one searchable table. Class, mechanism, phase and stack rule, filterable by side and phase. Built to answer one question quickly: are two things in my protocol doing the same job through the same mechanism, and is that why neither is working.
Every guide, one membership
This is one of seven guides in the library. A guides library membership opens all of them. Full Access adds the Protocol Builder, the Stack Visualizer and the research search engine on top of that. One price either way.
Research Protocol Bible
The whole framework in one place. The phase model for deciding what to run and when, every compound sorted by what it actually does, the bottlenecks that stall a protocol, and a full reference section. If the other guides are chapters, this is the spine they hang off.
Unlock with membershipRetatrutide From First Dose to Full Protocol
Retatrutide start to finish. What the third receptor actually changes, what the early weeks tend to look like, how researchers read the thermogenic signal, and where it sits alongside the compounds people run with it. Built for the protocol being planned around reta.
Unlock with membershipRetatrutide, Tesamorelin, Ipamorelin
Three compounds read as one system. How a fat loss driver, a growth hormone signal and its amplifier get sequenced so they support each other instead of colliding, and the redundancy that quietly leaves one of the three doing nothing.
Unlock with membershipStack Compatibility Guide
The one that tells you whether two things in your protocol are fighting each other. Which compounds share a receptor or a mechanism, which pairings are redundant, and which are genuinely additive. The guide to open before you add anything to what you already run.
Unlock with membershipMOTS-c and SS-31
The two mitochondrial compounds researchers confuse most, side by side. Which one restores and which one stimulates, the energy pattern each is actually for, and the single sequencing rule that decides which belongs in your phase.
Unlock with membershipMOTS-c Guide
MOTS-c on its own, in depth. The mechanism in plain English, the energy pattern it addresses, the signs it is working, and the phase where it helps against the phase where it makes things worse.
Unlock with membershipThe rest of this guide, and everything above
The Foundation Gate above is the whole guide in miniature. Same depth, same refusal to sell you a compound you do not need. A guides library membership opens the remaining seven sections here and every guide in the library. Full Access adds the research tools on top of that.
See membership options